Kovack Advisors’s Ocugen OCGN Stock Holding History

Kovack Advisors’s Portfolio OCGN Stock Details OCGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-17,335	Closed	-$23.4K	–	1079
2025 Q4	$23.4K	Buy	+17,335	New	+$24.7K	﹤0.01%	1009

Other funds holding OCGN

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Kovack Advisors's OCGN Position: Q1 2026 in Review

Kovack Advisors sold out of Ocugen (OCGN) in Q1 2026, closing a stake of 17,335 shares — an estimated $23.4K sold.

Kovack Advisors first reported a position in OCGN in Q4 2025 and held it in 1 quarter. The position peaked at $23.4K in Q4 2025. 137 funds tracked by Wall St. Rank hold OCGN as of Q1 2026.

Kovack Advisors reported no remaining Ocugen position as of Q1 2026 after selling out during the quarter.
Kovack Advisors sold 17,335 Ocugen shares in Q1 2026, an estimated $23.4K.
Kovack Advisors first reported a position in Ocugen in Q4 2025 and held it in 1 quarter.
Kovack Advisors's Ocugen position peaked at $23.4K in Q4 2025.
137 funds tracked by Wall St. Rank held Ocugen as of Q1 2026.

Based on Kovack Advisors's 13F filing for Q1 2026, filed 13 May 2026.